Avasopasem manganese - Galera Therapeutics
Alternative Names: Avasopasem; GC 4419Latest Information Update: 24 May 2024
At a glance
- Originator Galera Therapeutics
- Class Anti-inflammatories; Antifibrotics; Antineoplastics; Aza compounds; Chemoprotectants; Cyclohexanes; Pyridines; Small molecules
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended COVID 2019 infections; Head and neck cancer; Mucositis; Oesophagitis; Pancreatic cancer; Stomatitis; Unspecified
- Discontinued Fibrosis